Un programme intégré de recherche translationnelle en oncologie, consacré à l’épigénétique pour étudier la reprogrammation du paysage épigénétique, son rôle dans la résistance aux traitements et la prévention des rechutes.
As Europe's leading cancer centre, Gustave Roussy is now the first hospital to have joined the Cancer@Work corporate club, a public-interest association set up in 2012, dedicated to the subject of cancer and illness in the workplace.
Gustave Roussy is committed to setting up initiatives to help employees affected by cancer to integrate, stay in work and improve their quality of life at work.